Pulmonary Hypertension and Interstitial Lung Disease
The first edition of this book, published in 2009, was the only book of its kind dedicated exclusively to the diagnosis and management of pulmonary arterial hypertension (PAH) in patients with interstitial lung disease (ILD). Over the past few years, new
- PDF / 7,529,426 Bytes
- 216 Pages / 439.43 x 683.15 pts Page_size
- 69 Downloads / 208 Views
123
Pulmonary Hypertension and Interstitial Lung Disease
Robert P. Baughman • Roberto G. Carbone Steven D. Nathan Editors
Pulmonary Hypertension and Interstitial Lung Disease Second Edition
Editors Robert P. Baughman Department of Medicine University of Cincinnati Medical Center Cincinnati, OH, USA
Roberto G. Carbone Regional Hospital Aosta and University of Genoa Genoa, Italy
Steven D. Nathan Inova Fairfax Advanced Lung Disease and Transplant Program Inova Fairfax Hospital Falls Church, VA, USA
ISBN 978-3-319-49916-1 ISBN 978-3-319-49918-5 (eBook) DOI 10.1007/978-3-319-49918-5 Library of Congress Control Number: 2017942775 © Springer International Publishing AG 2009, 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Dr. Roberto Carbone wishes to dedicate this book to parents Attilia and Giuseppe Carbone.
Preface
Several years ago, Roberto Carbone began working on a book which would deal exclusively regarding pulmonary hypertension in interstitial lung disease. He asked Drs. Baughman and Bottino to join in this effort as editors and we solicited chapters from experts around the world on this subject. This led to the first edition of Pulmonary Arterial Hypertension in Interstitial Lung Disease which was published in 2010. In this edition, Dr. Baughman and Carbone are joined by Dr. Steven Nathan as the third co-editor. Since that time, several studies have been published regarding the diagnosis and management of pulmonary hypertension in interstitial lung disease. The terminology has changed and pulmonary arterial hypertension is reserved for WHO group 1 patients. Pulmonary hypertension in interstitial lung disease is cate
Data Loading...
